The committee will be co-chaired by John Levin, chair of the SHC Board of Directors, and Lloyd Minor, MD, dean of the School of Medicine.
October 2, 2015
Stanford Health Care’s board of directors has appointed a committee to immediately begin a nationwide search for a new CEO.
The current CEO, Amir Dan Rubin, will step down Jan. 4.
The committee is co-chaired by John Levin, chair of the SHC Board of Directors, and Lloyd Minor, MD, dean of the School of Medicine. The other members of the committee are Christopher Dawes, CEO of Lucile Packard Children’s Hospital Stanford; Norman Rizk, MD, chief medical officer of SHC; Robert Jackler, MD, professor and chair of otolaryngology; and SHC board members Bret Comolli, John Gunn, Fred Harman, Ron Johnson, Linda Meier and Mariann Byerwalter, who is former chair of the board.
“We are grateful to the members of the search committee for undertaking this critical role,” Minor and Levin said in a statement. “Our goal is to find a truly outstanding leader for SHC as is befitting the unique and preeminent role that Stanford Health Care plays not only in our community but nationally. We will be reaching out to the multiple constituencies of the Stanford Medicine family for input in this process. We are fortunate that we have excellent leadership at all levels of the organization that will continue the exciting momentum of SHC while we conduct this search.”
About Stanford Medicine
Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.
